Gregory P. Blair, MD, FCCP, FACP

(503) 297-3778
Areas of Focus: 
Thoracic Oncology
Pleural Disease
Complex Sleep Disorders
Advanced Interventional Pulmonary Procedures

About Me

My many years in the Portland area as a pulmonary and sleep medicine specialist have been very rewarding. I look forward to continuing to build rewarding relationships with my patients as we work together to address their medical issues.

- Gregory P. Blair, MD, FCCP, FACP

Dr. Gregory Blair earned his medical degree at the University of Utah College of Medicine. He completed his residency in Internal Medicine and his Pulmonary and Critical Care Fellowship University of California at Irvine. He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Disorders Medicine. He is the Medical Director, Sleep Disorder Disorders Center, Providence Newberg Medical Center. Dr. Blair’s areas of interest include thoracic oncology, pleural disease, and complex sleep disorders. Dr. Blair is also one of the few area doctors with expertise in advanced interventional pulmonary procedures.

Education & Honors

Board Certified: 
  • Internal Medicine
  • Pulmonary & Critical Care Medicine
Education & Training: 
  • B.S., Weber State University, Ogden, UT, 1973
  • M.D., University of Utah College of Medicine, Salt Lake City, UT, 1977
  • Residency, Internal Medicine, University of California Irvine, Irvine, CA, 1980
  • Fellowship, Pulmonary Medicine, University of California Irvine, Irvine, CA, 1982
Leadership: 
  • Medical Director, Sleep Disorder Disorders Center, Providence Newberg Medical Center
Honors: 
  • Medical Director, Sleep Disorder Disorders Center, Providence Newberg Medical Center
Publications: 
  • Brown SE, Blair GP, Chun OS, Lee HM, Vaques P, Minh VO: Metabolic significance of VEMA X and predictive value oftidal volume at exhaustion (VTMAX) for estimation of V02MAX in chronic obstructive pulmonary disease. Fed. Proc. 1980; 39; 1060.
  • Blair GP, Light R W: Treatment of COPD with corticosteroids: Comparison of daily versus alternate day therapy with placebo control. Am Rev Respir Dis 1981; 123 SuppI4:87. (Presented to Annual American Thoracic Society Meeting. 1981 )
  • Brown SE, Linden GS, Mintz HM, Blair GP, Stansbury DW, King RR, Light RW: The effects of Verapamil on pulmonary hemodynamics during induced hypoxemia and exercise in patients with obstructive lung disease. Am Rev Respir Dis 1982; 126 Supple 4: 81.
  • Belman MJ, Rambhtla K, Blair GP, Siek G: Breathlessness index, a simple and repeatable exercise test for patients with chronic obstructive pulmonary disease. AM Rev Respir Dis, 1983; 127 Supp14: 109
  • Brown SE, Linden GS, King RR, Blair GP, Stanbury DS. Light RW: Effects of Verapamil on pulmonary hemodynamics during hypoxemia, at rest, and during exercise in patients with chronic obstructive pulmonary disease. Thorax 1983; 840-844.
  • Blair GP, Light RW: Treatment of chronic obstructive pulmonary disease with corticosteroids. Chest 1984; 86: 524-528
  • Blair GP: Loss of fiberoptic laser ferrule. Chest 1986: 89: 903-904 (letter).
  • Blair GP, Sharpe LD: Nutrition support in respiratory disorders. Nutrition Clin Pract 1989; 4: 173-175.
Other Activities: 
  • Fellow, American College of Chest Physicians
  • Fellow, American College of Physicians
  • Member, Oregon Thoracic Society
  • Member, American Medical Association
  • Member, Washington County Medical Society
  • Member, Society of Critical Care Medicine